NCT05010720

Brief Summary

Axial Spondyloarthritis is an inflammatory arthritis disease and its main symptoms are chronic pain and stiffness, causing structural damage to the spinal vertebrae. Axial Spondyloarthritis leads to physical disability and a decrease in the level of physical activity. Frailty is a syndrome characterized by decline in physiological reserve and loss of muscle strength. Frailty can lead to vulnerability of individuals to possible injuries and a decrease in independence, and ultimately an increase in mortality. Although frailty is associated with older adults, it has been reported that it can be detected in patients with cancer, diabetes and rheumatological diseases and it is not related with age. Frailty has been reported to be a reversible and a treatable condition. The aim of our study was to investigate the prevalence of frailty and the relationship between frailty and disease activity, physical functional level, quality of life and other associated factors in individuals with Axial Spondyloarthritis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Aug 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 12, 2021

Completed
Same day until next milestone

Study Start

First participant enrolled

August 12, 2021

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 18, 2021

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 10, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 10, 2022

Completed
Last Updated

July 5, 2022

Status Verified

June 1, 2022

Enrollment Period

6 months

First QC Date

August 12, 2021

Last Update Submit

June 29, 2022

Conditions

Outcome Measures

Primary Outcomes (3)

  • Fried Frailty Phenotype

    The frailty level of the participants included in the study will be determined according to the frailty phenotype criteria of Fried et al. criteria for the diagnosis of frailty; Decreased grip strength, walking speed for 4 meters is less than the determined metrics ( for people who are 159 cm and shorter as \<6.12 sec or \>5.25 sec for those 159 cm and above), involuntary weight loss in the last year (≥4.5 kg) or body mass index ≤18.5 kg/m2, low physical activity level, and increased fatigue level reported by the participant. Individuals meeting 3 or more of these criteria are defined as "frail", individuals meeting 1 or 2 criteria are defined as "pre-fragile (pre-fragile) and individuals who do not meet any criteria are defined as "normal or robust".

    1 day

  • Kihon Checklist

    Frailty status will determined according to the Turkish version of the Kihon Checklist (KCL) which consists of 25 questions for yes (1) or no (0) answers. KCL includes seven categories as; physical function (5 items), mood (5 items), instrumental activities of daily life (5 items), nutrition (2 items), oral function (3 items), memory (3 items) and socialization (2 items). Total KCL scores range from 0 to 25 and scores ≥8 indicate frailty, between 4 to 7 indicate pre-frailty and between 0 to 3 indicate robustness.

    1 day

  • Short Physical Performance Battery(SPPB)

    SPPB can be used to determine frailty status. It comprises 3 parameters: static balance, sit to stand test and walking speed. Scores above 9 indicates no frailty, between 7 to 9 indicates pre-frailty and below 7 indicates frailty status.

    1 day

Secondary Outcomes (4)

  • Bath Ankylosing Spondylitis Disease Activity Index (BASDAI)

    1 day

  • Bath Ankylosing Spondylitis Functional Index (BASFI)

    1 day

  • Depression and Anxiety

    1 day

  • Ankylosing Spondylitis Quality of Life Scale

    1 day

Other Outcomes (3)

  • Gait Speed

    1 day

  • Grip Strength

    1 day

  • Physical Activity Level

    1 day

Eligibility Criteria

Age40 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients diagnosed with Axial Spondyloarthritis in a tertiary research and training hospital

You may qualify if:

  • Diagnosed with Axial Spondyloarthritis by an experienced rheumatologist.
  • To be between the ages of 40-65

You may not qualify if:

  • Severe comorbidities such as cancer and stroke
  • Being diagnosed with newly defined or recurrent cancer,
  • Not having enough cognitive skills to answer the questions,
  • Having neurological problems such as stroke
  • Having cognitive impariment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Haydarpaşa Numune Research and Training Hospital

Istanbul, Turkey (Türkiye)

Location

MeSH Terms

Conditions

FrailtyAxial Spondyloarthritis

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsSpondylarthropathiesSpondylarthritisSpondylitisSpinal DiseasesBone DiseasesMusculoskeletal DiseasesAnkylosisJoint DiseasesArthritis

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

August 12, 2021

First Posted

August 18, 2021

Study Start

August 12, 2021

Primary Completion

February 10, 2022

Study Completion

February 10, 2022

Last Updated

July 5, 2022

Record last verified: 2022-06

Locations